Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"Phase: Phase 2"
topic_facet:"Recruitment Status: Not yet recruiting"
topic_facet:"Medical Condition: Infection with SARS-CoV-2 virus, COVID-19 infection;Therapeutic area: Diseases [C] - Virus Diseases [C02]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Infection+with+SARS-CoV-2+virus%2C+COVID-19+infection%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Infection+with+SARS-CoV-2+virus%2C+COVID-19+infection%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Infection+with+SARS-CoV-2+virus%2C+COVID-19+infection%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (4)
1
Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to respiratory distress. : A phase 2/3, randomized, double blind, placebo-controlled study to evaluate theefficacy and the safety of ABX464 in treating inflammation and preventing COVID-19associated acute respiratory failure in patients aged >/= 65 and patients aged >/=18 withat least one additional risk factor who are infected with SARS-CoV-2. (the MiR-AGEstudy).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
2
Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to respiratory distress. : A phase 2/3, randomized, double blind, placebo-controlled study to evaluate theefficacy and the safety of ABX464 in treating inflammation and preventing COVID-19associated acute respiratory failure in patients aged >/= 65 and patients aged >/=18 withat least one additional risk factor who are infected with SARS-CoV-2. (the MiR-AGEstudy).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
3
Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to respiratory distress. : A phase 2/3, randomized, double blind, placebo-controlled study to evaluate theefficacy and the safety of ABX464 in treating inflammation and preventing COVID-19associated acute respiratory failure in patients aged = 65 and patients aged =18 withat least one additional risk factor who are infected with SARS-CoV-2. (the MiR-AGEstudy).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
4
Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to respiratory distress. : A phase 2/3, randomized, double blind, placebo-controlled study to evaluate theefficacy and the safety of ABX464 in treating inflammation and preventing COVID-19associated acute respiratory failure in patients aged = 65 and patients aged =18 withat least one additional risk factor who are infected with SARS-CoV-2. (the MiR-AGEstudy).
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Filter aufheben
Thema: Medical Condition: Infection with SARS-CoV-2 virus, COVID-19 infection;Therapeutic area: Diseases [C] - Virus Diseases [C02]
Medienart
4
Aufsätze
4
E-Artikel
4
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
4
610
Medical Condition: Infection with SARS-CoV-2 vi...
Phase: Phase 2
Recruitment Status: Not yet recruiting
4
Study Type: Interventional
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2019-2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4
Englisch
Haven't found what you're looking for?
Wird geladen...